Cardio Diagnostics Holdings, Inc.
Close on Oct 19, 2026
- Market cap
- $4.85M
- P/E (TTM)
- –
- Dividend yield
- –
Earnings
Quarterly results announced on Form 8-K, Item 2.02
No earnings releases found
Cardio Diagnostics has not filed an earnings release (Form 8-K, Item 2.02) that we could match to a fiscal quarter.
Press releases
Announcements Cardio Diagnostics filed with the SEC
Leading the Next Frontier in Precision Cardiovascular Medicine 2026 NASDAQ: CDIO 1
Regulation FD disclosure · EX-99.1 to Form 8-K
Leading the Next Frontier in Precision Cardiovascular Medicine 2026 NASDAQ: CDIO 1
Regulation FD disclosure · EX-99.1 to Form 8-K
DIAGNOSTICS HoldingS, INC. ANNOUNCES 1-for-30 reverse stock split
Charter or bylaw amendment · Regulation FD disclosure · EX-99.1 to Form 8-K
COMPANY UPDATE Revolutionizing Cardiovascular Medicine With Epigenetics and AI
Regulation FD disclosure · EX-99.1 to Form 8-K
COMPANY UPDATE Revolutionizing Cardiovascular Medicine With Epigenetics and AI MARCH 2024
Regulation FD disclosure · EX-99.1 to Form 8-K
Holdings, Inc. Regains Nasdaq Minimum Bid Price Requirement
Other events · EX-99.1 to Form 8-K
EX-99.1 to Form 8-K
Regulation FD disclosure · EX-99.1 to Form 8-K
EX-99.1 to Form 8-K
Regulation FD disclosure · EX-99.1 to Form 8-K
Cardio Diagnostics Holdings, Inc Announces
Material agreement · New financial obligation · Unregistered share sale · Regulation FD disclosure · Other events · EX-99.1 to Form 8-K
UNAUDITED PRO FORMA CONDENSED COMBINED FINANCIAL
Material agreement · Acquisition or disposition completed · Listing notice · Executive or director change · Charter or bylaw amendment · Shareholder vote results · Regulation FD disclosure · EX-99.1 to Form 8-K
Cardio Diagnostics Holdings, Inc. to List on Nasdaq
Material agreement · Acquisition or disposition completed · Listing notice · Executive or director change · Charter or bylaw amendment · Shareholder vote results · Regulation FD disclosure · EX-99.2 to Form 8-K
Mana Capital Acquisition Corp. Announces Intention
New financial obligation · Other events · EX-99.1 to Form 8-K
Mana Capital Acquisition Corp. Confirms
New financial obligation · Other events · EX-99.2 to Form 8-K
Diagnostics Announces Issuance of U.S. Patent for
Regulation FD disclosure · EX-99.1 to Form 8-K
Mana Capital Acquisition Corp. Announces Intention
New financial obligation · Other events · EX-99.1 to Form 8-K
Mana Capital Acquisition Corp. Confirms
New financial obligation · Other events · EX-99.2 to Form 8-K
Capital Acquisition Corp. and Cardio Diagnostics, Inc.
Material agreement · Unregistered share sale · Regulation FD disclosure · EX-99.1 to Form 8-K
Mana Capital Acquisition Corp. Announces
Other events · EX-99.1 to Form 8-K
Actual as of November 26, 2021
Unregistered share sale · Other events · EX-99.1 to Form 8-K
Audited Financial Statement of Mana Capital Acquisition Corp.:
Unregistered share sale · Other events · EX-99.1 to Form 8-K
Mana Capital Acquisition Corp. Announces
Material agreement · Unregistered share sale · Charter or bylaw amendment · Other events · EX-99.1 to Form 8-K
Mana Capital Acquisition Corp. Announces
Material agreement · Unregistered share sale · Charter or bylaw amendment · Other events · EX-99.2 to Form 8-K